Skip to content
Black Week: 20% off everything, code BLACK

Search

What are you looking for?

Type at least 2 characters to see suggestions.

Quality and Legal Status Marek Wawrzyk

How to Read a Certificate of Analysis (COA): What It Documents and What It Cannot Guarantee

A Certificate of Analysis is often treated as a seal of quality: if a document exists, the material must be acceptable.

How to Read a Certificate of Analysis (COA): What It Documents and What It Cannot Guarantee

A Certificate of Analysis is often treated as a seal of quality: if a document exists, the material must be acceptable. That is an overinterpretation. A COA is a record of specific tests performed on a specific batch. It states exactly what was tested, and nothing more. Reading it correctly requires both understanding the reported results and noticing what the document does not contain.

This article explains the individual sections of a typical certificate, shows how to interpret the figures, and identifies situations in which the document does not support the conclusions attributed to it.

What Is a Certificate of Analysis?

A COA (Certificate of Analysis) is a document issued after a specific batch of material has been tested. It lists the tests performed, the results obtained, and the applicable acceptance criteria. Three parts of that definition deserve immediate emphasis:

  • It applies to a batch, not to a product in general. A certificate for a batch produced in March says nothing about a batch produced in September.
  • It covers only the tests that were actually performed. If “endotoxins” is absent, endotoxins were not tested; it does not mean they are absent.
  • It is a record, not an assessment. It reports a result, not an opinion on whether the material is suitable for a particular purpose.

The system-level context for this type of documentation for synthetic peptides, including the role of reference standards, is discussed in a paper on quality standards (McCarthy et al., 2023, PMID 36949371). Broader regulatory challenges in the development of peptide therapeutics are reviewed separately (Zane et al., 2021, PMID 33327828).

HPLC: Chromatographic Purity

High-performance liquid chromatography separates a mixture into components that leave the column at different times. The result is a chromatogram, a plot on which each detected component produces a peak.

What Does “Purity ≥98%” Mean?

This figure is calculated from peak area. The areas of all peaks in the chromatogram are added together, and the percentage contributed by the main peak is calculated. A result of 98% therefore means: the main peak accounts for 98% of the combined area of all recorded peaks.

This wording entails three limitations that are rarely mentioned:

  • It applies only to substances that produced a peak. Components that do not absorb at the selected wavelength or do not leave the column under the analytical conditions are not included in the calculation. Salts, residual solvents, and water are usually not represented.
  • Peak area is not mass. The calculation assumes a similar detector response for all components, which is not always the case.
  • It does not identify the main peak. Chromatography separates components; a different method is needed to establish identity.

What to Check on a Chromatogram

  • The number and size of secondary peaks — one secondary peak with an area of 1.5% is different from fifteen peaks of 0.1% each.
  • Resolution — overlapping peaks make reliable integration more difficult.
  • Baseline quality — drift or noise can affect the integration result.

Mass Spectrometry: Identity

This provides different information from purity, although the two are often confused on certificates. Mass spectrometry measures the mass-to-charge ratio of ions. This makes it possible to determine the molecular mass of the tested compound and compare it with the mass calculated for the declared sequence. A methodological paper describes the characterization of synthetic peptides using this technique (Chrone et al., 2024, PMID 38997482).

Distinguishing these two types of information is fundamental to reading a COA:

Question Method What It Shows
How much of the detected material is the main component? HPLC The main peak’s share of the total recorded peak area
Is the compound the declared one? Mass spectrometry Agreement between the measured mass and the mass calculated for the sequence

A certificate that reports only HPLC purity, without confirming identity, does not establish what is in the vial. It may show that the detected material is relatively homogeneous, but not that it is the substance stated on the label.

A Limitation That Is Rarely Discussed

Molecular mass cannot distinguish between molecules with identical atomic composition. Two peptides with the same sequence but a different spatial configuration at a single amino acid residue have the same mass. A separate review addresses the enantiomeric purity of therapeutic peptides (Badgujar et al., 2024, PMID 38448043). This is a practical concern because epimerization is a known side reaction in peptide synthesis.

The practical conclusion is that agreement in mass and high HPLC purity do not rule out the presence of isomers that neither method necessarily distinguishes.

Endotoxins

Endotoxins are lipopolysaccharides originating from the cell wall of Gram-negative bacteria. They are heat-stable and can survive sterilization procedures that kill the bacteria themselves. This creates an apparently contradictory situation: material may be sterile and still contain a significant amount of endotoxin.

The traditional test uses Limulus amebocyte lysate (LAL). The development of this method, together with the recombinant factor C alternative, is discussed in a review (Ding and Ho, 2010, PMID 20593268), while the practical implementation of the recombinant method is covered separately (Tindall et al., 2021, PMID 33956506). The two approaches have been compared in materials with complex matrices (Marius et al., 2020, PMID 32179709) and with respect to detection specificity (Dubczak et al., 2021, PMID 33454378).

When reading this section, check the unit. Results are reported in endotoxin units per milligram or milliliter (EU/mg or EU/mL). A result stated merely as “negative,” without a method and detection limit, provides little information.

Other Items on a COA

  • Water content — usually measured by Karl Fischer titration. This matters for lyophilized material because residual water accelerates degradation during storage.
  • Residual solvents — residues from synthesis and purification, typically measured by gas chromatography.
  • Net peptide content — a separate value from purity. Material with 99% chromatographic purity may contain a substantial amount of counterion salt, so the mass of peptide itself may be lower than the total weighed mass.
  • Appearance — the color and physical form of the material.

Batch Identification: Without It, the Document Has No Value

This determines whether the certificate is useful at all. A COA without a batch number cannot be linked to the material in hand and therefore proves nothing about that material.

The certificate should include a batch number matching the identifier on the packaging, the test date, the name of the laboratory that performed the analysis, and the methods used. The ability to link the document to a specific container is the essence of traceability.

Red Flags

  • No batch number, or a number that does not match the packaging.
  • No test date — an analytical result is not timeless.
  • No laboratory name or information that makes the laboratory identifiable.
  • The same document used for multiple batches — this contradicts the definition of a batch certificate.
  • A chromatogram shown as an image without axes or scale — resolution and baseline quality cannot be assessed.
  • Purity reported without a method — “99%” without the analytical technique and test conditions.
  • No identity confirmation despite an HPLC purity result.
  • A result reported only as “complies”, without a numerical value and acceptance criterion.

What a COA Does Not Guarantee

This is the most important section of the article.

  • It does not guarantee that the document applies to your container unless the batch numbers match.
  • It does not guarantee the material’s current condition. Testing was performed on a specific date; material stored under unsuitable conditions may have changed since then.
  • It does not guarantee the absence of isomers — HPLC purity and mass agreement do not establish the spatial configuration of amino acid residues (PMID 38448043).
  • It does not guarantee that impurities are harmless. Even small quantities of peptide impurities may be immunologically relevant. A separate paper addresses immunogenicity risk assessment for such impurities (De Groot et al., 2023, PMID 37467878), and an analysis involving a specific peptide was published separately (Roberts et al., 2024, PMID 39185315).
  • It does not guarantee sterility unless a sterility test was performed.
  • It does not make the material suitable for human use. A certificate describes physicochemical properties; it does not change the material’s regulatory status.

The final point deserves emphasis: good analytical documentation does not turn a research reagent into an approved medicinal product. These are two independent considerations: the analytical quality of the material and the legal basis on which it is supplied.

Frequently Asked Questions

Is 99% Purity Better Than 98%?

The numerical difference alone says less than it may appear to. What matters is the method used to determine purity, which peaks were included in the reference area, and the distribution of secondary peaks. A result without a description of the method cannot be reliably compared with another result.

Does HPLC Confirm That It Is the Correct Peptide?

No. Chromatography separates a mixture and helps assess its homogeneity. Identity is confirmed by mass spectrometry, which compares the measured molecular mass with the mass calculated for the declared sequence.

Is Sterile Material Free of Endotoxins?

No. Endotoxins are heat-stable and may survive procedures that destroy bacteria. Sterility and endotoxin content are two independent tests.

Is a COA Without a Batch Number Worth Anything?

No. Without a batch number, the document cannot be linked to the material in hand and therefore proves nothing about it.

Does a Certificate Mean That the Material Can Be Used in Humans?

No. Analytical documentation describes the physicochemical properties of a batch. It does not change the material’s regulatory status or constitute marketing authorization.

Summary

A Certificate of Analysis is a record of tests performed on a specific batch and says exactly as much as those tests establish. Chromatographic purity is calculated from the main peak’s share of the combined area of all recorded peaks. It therefore excludes components that did not produce a peak and does not identify the main peak. Mass spectrometry provides evidence of identity, but it also has limits: molecules that differ only in the spatial configuration of amino acid residues can have the same mass, and epimerization is a known side reaction in peptide synthesis. Endotoxins require a separate test because they are heat-stable and may survive procedures that destroy bacteria; material can be sterile and still contain endotoxins. The batch number remains the document’s decisive identifier: without it, the certificate cannot be linked to the material in hand. Finally, analytical documentation describes physicochemical properties, but it neither changes the regulatory status of the material nor makes it suitable for human use.

Product Documentation

This article summarizes the principles used to review batch analytical documentation. Practical considerations for working with research material, including solvent selection, are discussed in our article on bacteriostatic water.

Bibliography

  1. McCarthy D, Han Y, Carrick K, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023;40(6):1317–1328. PMID: 36949371
  2. Chrone VG, Lorentzen A, Højrup P. Characterization of Synthetic Peptides by Mass Spectrometry. Methods Mol Biol. 2024;2821:83–89. PMID: 38997482
  3. Badgujar D, Paritala ST, Matre S, Sharma N. Enantiomeric purity of synthetic therapeutic peptides: A review. Chirality. 2024;36(3):e23652. PMID: 38448043
  4. De Groot AS, Roberts BJ, Mattei A, Lelias S, Boyle C, Martin WD. Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discov Today. 2023;28(10):103714. PMID: 37467878
  5. Roberts BJ, Mattei AE, Howard KE, et al. Assessment of salmon calcitonin peptide impurities using in silico and in vitro methods. Front Pharmacol. 2024;15:1363139. PMID: 39185315
  6. Zane D, Feldman PL, Sawyer T, Sobol Z, Hawes J. Development and Regulatory Challenges for Peptide Therapeutics. Int J Toxicol. 2021;40(2):108–124. PMID: 33327828
  7. Ding JL, Ho B. Endotoxin detection — from limulus amebocyte lysate to recombinant factor C. Subcell Biochem. 2010;53:187–208. PMID: 20593268
  8. Tindall B, Demircioglu D, Uhlig T. Recombinant bacterial endotoxin testing: a proven solution. Biotechniques. 2021;70(5):290–300. PMID: 33956506
  9. Marius M, Vacher F, Bonnevay T. Comparison of Limulus Amoebocyte Lysate and Recombinant Factor C Assays for Endotoxin Detection in Four Human Vaccines with Complex Matrices. PDA J Pharm Sci Technol. 2020;74(4):394–407. PMID: 32179709
  10. Dubczak J, Reid N, Tsuchiya M. Evaluation of limulus amebocyte lysate and recombinant endotoxin alternative assays for an assessment of endotoxin detection specificity. Eur J Pharm Sci. 2021;159:105716. PMID: 33454378